Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 11/22/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol Myers Squibb Merck & Co., Inc. Nektar Therapeutics |
None | None | None | ✔ |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta EMD Serono Merck & Co., Inc. Physical Sciences Incorporated (through subcontracted funds from NIH) Regeneron Pharmactcls |
Castle Biosciences Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Joel Baumgartner MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Genevieve Boland MD, PhD | InterVenn Biosciences Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. Teiko |
Ankyra Therapeutics Instil Bio InterVenn Biosciences Iovance pharmaceuticals Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | Ankyra | - |
| Bartosz Chmielowski MD, PhD | Adagene Advenchen Laboratories Ascentage Atreca Bristol Myers Squibb Compugen Daiichi- Sankyo Co. Delcath IDEAYA Biosciences Idera Immunocore Infinity Pharmaceuticals, Inc InstilBio Iovance Karyopharm Therapeutics Macrogenics Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation PACT Pharma RAPT Therapeutics Replimune Xencor |
Delcath Expert Witness InstilBio Nektar Therapeutics Novartis Pharmaceuticals Corporation |
None | None | - |
| Dominick DiMaio MD | None | None | None | None | ✔ |
| Roxana Dronca MD | Alkermes Bristol Myers Squibb Emerson Collective Phosplatin Therapeutics Regeneron Pharmactcls Sorento Therapeutics |
Bristol Myers Squibb Eisai Inc. Elsevier, Inc. EMD Serono Genzyme Corporation Immunovaccine Technologies Natera |
Bristol Myers Squibb Eisai Inc. Elsevier, Inc. EMD Serono Genzyme Corporation Immunovaccine technologies Natera |
None | ✔ |
| Ryan Fields MD | None | None | None | None | ✔ |
| Martin Fleming MD, FACS | Castle Biosciences | Castle Biosciences | None | None | ✔ |
| Anjela Galan MD | None | None | None | None | ✔ |
| Brian Gastman MD | Alkermes InstilBio Merck NIT |
BMS InstilBio Iovance Merck |
Castle Biosciences Quest Imaging |
Cutaneous Malignancies: A Surgical Perspective 1st Edition | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Samantha Guild JD | None | Melanoma Research Program (CDMRP) State of Texas |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Ashley Holder MD | None | None | None | None | ✔ |
| John Hyngstrom MD | Amgen Inc. Bristol Myers Squibb Checkmate Iovance pharmaceuticals Lokon Merck & Co., Inc. Morphogenesis Naterra National Cancer Institute Oncosec Philogen |
None | None | None | ✔ |
| Douglas Johnson MD, MSCI | None | None | Bristol Myers Squibb Catalyst Biopharma Iovance Mallinckrodt Merck & Co., Inc. Mosaic ImmunoEngineering Novartis Pharmaceuticals Corporation Pfizer Inc. Teiko |
Patent for MHC-II as a biomarker for immunotherapy response|Patient for abatacept or belatacept as treatment for refractory irAEs | ✔ |
| Madeline Joyce BSN, RN, OCN | None | None | None | None | - |
| Giorgos Karakousis MD | Merck & Co., Inc. | Merck & Co., Inc. | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Kari Kendra MD, PhD | Amgen Inc. checkmate pharmaceuticals Istari oncology Karyopharm Therapeutics medspace Merck & Co., Inc. National Institute on Aging Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | None | ✔ |
| Maija Kiuru MD, PhD | CalDerm NanoString Technologies, Inc. |
None | None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | - |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Ryan Lanning MD, PhD | None | None | None | None | ✔ |
| Theodore Logan MD, FACP | Abbott Laboratories Abraxis Bioscience, Inc. Acceleron Pharma, Inc. Amgen Inc. Argos Therapeutics AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. Biovex Bristol Myers Squibb Cerulean Pharma Dynavax Technologies Eisai Inc. Eli Lilly and Company EMD Serono GSK Immatics Iovance pharmaceuticals MacroGenics MedImmune Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. NiKang Therapeutics Novartis Pharmaceuticals Corporation Peloton Therapeutics, Inc. Pfizer Inc. Prometheus Roche Laboratories, Inc. Synta Pharmaceuticals Corp. Threshold Pharmaceuticals TRACON Pharmaceuticals, Inc. |
None | None | None | ✔ |
| Senem Lubin PhD, MBA | None | None | None | None | - |
| Miguel Materin MD | None | Castle Biosciences | None | None | - |
| Lisa McKale | None | None | None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Anthony Olszanski MD, RPh | Alkermes Astellas Pharma US, Inc. Bristol Myers Squibb Checkmate Elucida Fate Glyconex GSK InstilBio Intensity Istari Kadmon Kartos Kezar Kinnate OncoSec SpringBank Sumitomo Dainippon Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb Eisai Inc. InstilBio Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Patrick Ott MD, PhD | Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. Oncorus Xencor |
Bristol Myers Squibb Evaxion Merck & Co., Inc. Pfizer Inc. Phio |
None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
Amgen Inc. | None | ✔ |
| April Salama MD | Bristol Myers Squibb Ideaya Immunocore Merck & Co., Inc. Nektar Therapeutics Olatec Regeneron Pharmactcls Replimune Seattle Genetics, Inc. |
Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Rohit Sharma MD | None | None | None | None | ✔ |
| Arun Singh MD | None | AURA ISOAID LLC |
Immunocore | AURA | - |
| Joseph Skitzki MD | None | None | None | None | ✔ |
| Emily Smith MD, FAAD | None | None | Gather-Ed | None | ✔ |
| Jeffrey Sosman MD | None | Array Jazz Pharmaceuticals Inc. Nektar Therapeutics Pfizer Inc. |
None | None | - |
| Andrew Stacey MD, MS | None | None | None | None | - |
| Susan Swetter MD | None | None | None | None | ✔ |
| John Thompson MD | None | Mabquest | None | None | ✔ |
| Katy Tsai MD | Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec Pfizer Inc. Replimune |
Bristol Myers Squibb | None | None | ✔ |
| Evan Wuthrick MD | None | None | Alpha Tau Castle Biosciences Viewray |
None | ✔ |
| Yan Xing MD, PhD | None | None | None | None | ✔ |